- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: refractory multiple myeloma
Total 20465 results
-
He HuangYake Biotechnology Ltd.RecruitingRelapse/Refractory Multiple MyelomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingMultiple MyelomaAustralia
-
M.D. Anderson Cancer CenterRecruiting
-
Intergroupe Francophone du MyelomeJanssen-Cilag Ltd.Recruiting
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada, Germany
-
Kathleen DorritieBristol-Myers SquibbRecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
Nanjing Leads Biolabs Co.,LtdRecruitingRelapsed/Refractory Multiple MyelomaChina
-
Hrain Biotechnology Co., Ltd.Shanghai Changzheng HospitalRecruitingMultiple Myeloma | Plasma Cell LeukemiaChina
-
Wuhan Union Hospital, ChinaGuangzhou Bio-gene Technology Co., LtdRecruiting
-
Abdullah KhanRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Medical College of WisconsinNot yet recruiting
-
SCRI Development Innovations, LLCJanssen Research & Development, LLCRecruiting
-
iOMEDICO AGStemline Switzerland GmbH; Climedo Health GmbHRecruitingMultiple MyelomaAustria, Germany
-
Genentech, Inc.RecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Australia, Israel
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
Qilu Pharmaceutical Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
UNC Lineberger Comprehensive Cancer CenterGenzyme, a Sanofi CompanyRecruitingMultiple Myeloma | Aging | Relapse | Co-morbidity | RefractoryUnited States
-
Institute of Hematology & Blood Diseases HospitalChina Immunotech (Beijing) Biotechnology Co., Ltd.Not yet recruitingRelapsed or Refractory Multiple MyelomaChina
-
Dong-A University HospitalNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
IGM Biosciences, Inc.RecruitingMultiple MyelomaUnited States
-
IDP Discovery Pharma S.L.RecruitingChronic Lymphocytic Leukemia (CLL) | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Multiple Myeloma (MM) | High Grade B-Cell Lymphoma, Not Otherwise Specified | Double Hit Lymphoma | Triple Hit LymphomaSpain
-
Carl Ola Landgren, MD, PhDBristol-Myers SquibbRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Aibin Liang,MD,Ph.D.CARsgen Therapeutics Co., Ltd.RecruitingRelapsed and/or Refractory Multiple Myeloma | Plasma Cell Leukemia in RelapseChina
-
Joshua Sasine, MD, PhDRecruitingMultiple Myeloma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Hematologic Malignancy | Large B-cell LymphomaUnited States
-
GI Cell, Inc.RecruitingAdvanced Solid Tumors | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Non-Hodgkin LymphomaKorea, Republic of
-
Cristiana Costa Chase, DONot yet recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Ichnos Sciences SANot yet recruitingRelapsed/Refractory Multiple MyelomaAustralia
-
Second Affiliated Hospital of Soochow UniversityThe Affiliated Hospital of Xuzhou Medical UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
Universitätsklinikum Hamburg-EppendorfRecruitingMultiple Myeloma | Multiple Myeloma in RelapseGermany
-
Gracell Biopharmaceuticals, Inc.RecruitingRelapsed/ Refractory Multiple MyelomaUnited States
-
Mayo ClinicRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
SanofiRecruitingRelapsed/Refractory Multiple Myeloma | Amyloid Light-chain AmyloidosisItaly, Australia, Hungary, United Kingdom, Czechia, Belgium, Spain
-
Technische Universität DresdenGerman Cancer Research CenterRecruitingNeoplasms | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)Germany
-
The First Affiliated Hospital of Soochow UniversityCARsgen Therapeutics Co., Ltd.RecruitingMultiple Myeloma | Plasma Cell LeukemiaChina
-
Masonic Cancer Center, University of MinnesotaRecruitingFollicular Lymphoma | Myelodysplastic Syndromes | Leukemia, Myeloid | Myelofibrosis | Burkitt Lymphoma | Marginal Zone Lymphoma | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Plasma Cell Leukemia | Myeloproliferative Neoplasm | Small Lymphocytic... and other conditionsUnited States
-
University of PennsylvaniaGenentech, Inc.Recruiting
-
Nanjing IASO Biotechnology Co., Ltd.Ruijin HospitalRecruitingPlasma Cell Leukemia | Relapsed/Refractory Multiple MyelomaChina
-
XuYanRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryChina
-
Zhejiang UniversityHangzhou Cheetah Cell Therapeutics Co., LtdRecruiting
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingMultiple MyelomaChina
-
PfizerRecruitingRefractory Multiple Myeloma | Relapse Multiple MyelomaItaly
-
920th Hospital of Joint Logistics Support Force...RecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryChina
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Taiwan, Spain, Australia, Brazil, France, United Kingdom, Poland, Singapore, Italy
-
Caribou Biosciences, Inc.RecruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingRelapsed and/or Refractory Multiple MyelomaChina
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Poland, Taiwan, Korea, Republic of, Japan, United Kingdom, Brazil, Mexico, Turkey, Argentina
-
SanofiRecruitingRelapsed/Refractory Multiple MyelomaCzechia, Japan, Australia, Brazil, Greece, Portugal
-
Nanjing IASO Biotherapeutics Co.,LtdNot yet recruiting
-
PfizerRecruiting
-
All4CureGlaxoSmithKlineRecruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma, RefractoryUnited States